OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros® 1 Platform
Go back to OPKO Health Submits Premarket Approval Application with FDA for a Point-of-Care PSA Test with the Claros® 1 Platform| OPKO HEALTH, Inc. (NASDAQ: OPK) | Delayed: 1.73 +0.04 (2.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.69 | 52 Week High | $11.85 | |||
| Open | $1.70 | 52 Week Low | $7.12 | |||
| Day High | $1.75 | P/E | N/A | |||
| Day Low | $1.69 | EPS | $-0.30 | |||
| Volume | 1,325,780 | |||||
